A step forward in molecular diagnostics of lyssaviruses:results of a ring trial among European laboratories

Rabies is a lethal and notifiable zoonotic disease for which diagnostics have to meet the highest standards. In recent years, an evolution was especially seen in molecular diagnostics with a wide variety of different detection methods published. Therefore, a first international ring trial specifical...

Descripción completa

Detalles Bibliográficos
Autores: Fischer, Melina, Wernike, Kerstin, Freuling, Conrad M, Müller, Thomas, Aylan, Orhan, Brochier, Bernard, Cliquet, Florence, Vázquez-Morón, Sonia, Hostnik, Peter, Huovilainen, Anita, Isaksson, Mats, Kooi, Engbert A, Mooney, Jean, Turcitu, Mihai, Rasmussen, Thomas B, Revilla-Fernández, Sandra, Smreczak, Marcin, Fooks, Anthony R, Marston, Denise A, Beer, Martin, Hoffmann, Bernd
Tipo de recurso: artículo
Fecha de publicación:2013
País:España
Institución:Instituto de Salud Carlos III (ISCIII)
Repositorio:Repisalud
Idioma:inglés
OAI Identifier:oai:repisalud.isciii.es:20.500.12105/6814
Acceso en línea:http://hdl.handle.net/20.500.12105/6814
Access Level:acceso abierto
Palabra clave:Animals
Europe
Female
Humans
Lyssavirus
Male
RNA, Viral
Reverse Transcriptase Polymerase Chain Reaction
Descripción
Sumario:Rabies is a lethal and notifiable zoonotic disease for which diagnostics have to meet the highest standards. In recent years, an evolution was especially seen in molecular diagnostics with a wide variety of different detection methods published. Therefore, a first international ring trial specifically designed on the use of reverse transcription polymerase chain reaction (RT-PCR) for detection of lyssavirus genomic RNA was organized. The trial focussed on assessment and comparison of the performance of conventional and real-time assays. In total, 16 European laboratories participated. All participants were asked to investigate a panel of defined lyssavirus RNAs, consisting of Rabies virus (RABV) and European bat lyssavirus 1 and 2 (EBLV-1 and -2) RNA samples, with systems available in their laboratory. The ring trial allowed the important conclusion that conventional RT-PCR assays were really robust assays tested with a high concordance between different laboratories and assays. The real-time RT-PCR system by Wakeley et al. (2005) in combination with an intercalating dye, and the combined version by Hoffmann and co-workers (2010) showed good sensitivity for the detection of all RABV samples included in this test panel. Furthermore, all used EBLV-specific assays, real-time RT-PCRs as well as conventional RT-PCR systems, were shown to be suitable for a reliable detection of EBLVs. It has to be mentioned that differences were seen in the performance between both the individual RT-PCR systems and the laboratories. Laboratories which used more than one molecular assay for testing the sample panel always concluded a correct sample result. Due to the markedly high genetic diversity of lyssaviruses, the application of different assays in diagnostics is needed to achieve a maximum of diagnostic accuracy. To improve the knowledge about the diagnostic performance proficiency testing at an international level is recommended before using lyssavirus molecular diagnostics e.g. for confirmatory testing.